Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Dec 02, 2008 07:30 AM
- Targeted Genetics' Board of Directors Appoints B.G. Susan Robinson, President and CEO, as Director
Nov 17, 2008 07:30 AM
- Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Nov 10, 2008 07:30 AM
- Targeted Genetics Reports Third Quarter 2008 Financial Results
Nov 05, 2008 04:00 PM
- Targeted Genetics to Host Conference Call and Webcast Discussion of Third Quarter Results on November 5, 2008
Oct 28, 2008 07:30 AM
- Targeted Genetics Announces Presentation of Data From Completed Phase 1/2 tgAAC94 Trial at American College of Rheumatology
Oct 27, 2008 07:30 AM
- Targeted Genetics Reports Second Quarter 2008 Financial Results
Aug 06, 2008 07:30 AM
- Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter Results on August 6, 2008
Jul 29, 2008 07:30 AM
- Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Department of Defense
Jul 10, 2008 07:30 AM
- Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Jun 12, 2008 01:00 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
TGEN
|
Compare to S&P
|
| YTD |
-85.71 %
|
-0.01 %
|
| 4 Weeks |
-52.17 %
|
-43.38 %
|
| 12 Weeks |
-66.67 %
|
-48.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 36.84 %
|
|
EPS Growth in Last Year: 20.00 %
|
|
Sales Growth in Last Quarter: -22.13 %
|
|
Sales Growth in Last Quarter: -28.69 %
|
|
|
